Eric Wenzler at College of Pharmacy - Research Interests, Publications & Academic Profile

Eric Wenzler

University Name

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

50%

Pharmacology

20%

Antibiotic Therapy

70%

Antimicrobial Research

50%

Antibiotic Resistance

30%

Pharmacovigilance

20%

Clinical Chemistry

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Pharmacokinetics and dialytic clearance of baricitinib during in vivo continuous venovenous haemodialysis in a patient with COVID-19

Article Link

Year:

2023

Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists

Article Link

Year:

2023

Universal admission testing with a rapid molecular point-of-care test and real-time polymerase chain reaction (PCR) assay for the detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Comparative performance and infection prevention implications

Article Link

Year:

2023

Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy

Article Link

Year:

2022

Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values

Article Link

Year:

2022

Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales

Article Link

Year:

2022

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility

Article Link

Year:

2022

Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales

Article Link

Year:

2022

Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States

Article Link

Year:

2022

Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach

Article Link

Year:

2022

Collaborators2

David Butler

Assistant Professor

Albany College of Pharmacy and Health Sciences

UNITED STATES

Zackery Bulman

University of Chicago

UNITED STATES

How do Indian students reach out?

Meet Kite AI